The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases

Autor: Jaume Alijotas-Reig, Raquel Ferrer-Oliveras, Amelia Ruffatti, Angela Tincani, Elmina Lefkou, Ma. Tiziana Bertero, Emmanuel Coloma-Bazan, Sara de Carolis, Gerard Espinosa, Patrizia Rovere-Querini, Anna Kuzenko, Enrique E. Valverde, Angel Robles, Ricard Cervera, Valentina Canti, Micaela Fredi, Antonio Gil-Aguado, Krista Lundelin, Elisa Llurba, Taisiya Melnychuk, Cecilia Nalli, Elisa Picardo, Erika Silvestro, Teresa del Ross, Inmaculada Farran-Codina
Přispěvatelé: Alijotas-Reig, J, Ferrer-Oliveras, R, Ruffatti, A, Tincani, A, Lefkou, E, Bertero, Mt, Coloma-Bazan, E, de Carols, S, Espinosa, G, Rovere Querini, P, Kuzenko, A, Valverde, Ee, Robles, A, Cervera, R, Canti, V, Fredi, M, Gil-Aguado, A, Lundelin, K, Llurba, E, Melnychuk, T, Nalli, C, Picardo, E, Silvestro, E, del Ross, T, Farran-Codina, I
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Popis: To analyse the clinical features, laboratory data, foetal-maternal outcomes, and follow-up in a cohort of 247 women with obstetric antiphospholipid syndrome (OAPS).The European Registry on APS became a Registry within the framework of the European Forum on Antiphospholipid Antibody projects and placed on a website in June 2010. Cases with obstetric complaints related to aPL who tested positive for aPL prospectively and retrospectively were included. The three-year survey results are reported.338 women with 1253 pregnancy episodes were included; 915 were historical and 338 were latest episodes. All these women tested positive for aPL. 247 of the 338 fulfilled the Sydney criteria. According to the laboratory categories, 84/247 were in category I, 42 in IIa, 66 in IIb and 55 in IIc. Obstetric complications other than foetal losses, appeared in 129 cases (52.2%). 192 (77.7%) had a live birth and 55 (22.3%) did not. The latter group of only 38 cases (69%) received adequate treatment and 17 (31%) did not. 177/247 (72%) women were put on heparin plus LDA. Thrombosis appeared in two during pregnancy and in 14 during the puerperium. 7 (3%) women evolved to complete SLE.OAPS shows differential characteristics than classical APS. All laboratory test categories are needed to avoid false-negative diagnoses. In some cases, complement levels could act as a serological marker. OAPS has very good foetal-maternal outcomes when treated. Thrombosis and progression to SLE in mothers with OAPS are scarce compared with "classical APS", suggesting that they have different aPL-mediated pathogenic mechanisms.
Databáze: OpenAIRE